{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:48:12Z","timestamp":1770742092466,"version":"3.49.0"},"reference-count":163,"publisher":"Georg Thieme Verlag KG","issue":"03","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Respir Crit Care Med"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The administration of exogenous oxygen to support adequate gas exchange is the cornerstone of respiratory care. In the past few years, other gaseous molecules have been introduced in clinical practice to treat the wide variety of physiological derangement seen in critical care patients.<\/jats:p><jats:p>Inhaled nitric oxide (NO) is used for its unique selective pulmonary vasodilator effect. Recent studies showed that NO plays a pivotal role in regulating ischemia-reperfusion injury and it has antibacterial and antiviral activity.<\/jats:p><jats:p>Helium, due to its low density, is used in patients with upper airway obstruction and lower airway obstruction to facilitate gas flow and to reduce work of breathing.<\/jats:p><jats:p>Carbon monoxide (CO) is a poisonous gas that acts as a signaling molecule involved in many biologic pathways. CO's anti-inflammatory and antiproliferative effects are under investigation in the setting of acute respiratory distress and idiopathic pulmonary fibrosis.<\/jats:p><jats:p>Inhaled anesthetics are widely used in the operative room setting and, with the development of anesthetic reflectors, are now a valid option for sedation management in the intensive care unit.<\/jats:p><jats:p>Many other gases such as xenon, argon, and hydrogen sulfide are under investigation for their neuroprotective and cardioprotective effects in post-cardiac arrest syndrome.<\/jats:p><jats:p>With all these therapeutic options available, the clinician must have a clear understanding of the physiologic basis, therapeutic potential, and possible adverse events of these therapeutic gases. In this review, we will present the therapeutic gases other than oxygen used in clinical practice and we will describe other promising therapeutic gases that are in the early phases of investigation.<\/jats:p>","DOI":"10.1055\/s-0042-1747966","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T22:38:55Z","timestamp":1652135935000},"page":"440-452","source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic Gases and Inhaled Anesthetics as Adjunctive Therapies in Critically Ill Patients"],"prefix":"10.1055","volume":"43","author":[{"given":"Stefano","family":"Gianni","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Valsecchi","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Berra","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2022,5,9]]},"reference":[{"issue":"03","key":"ref1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00000542-199303000-00005","article-title":"Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation","volume":"78","author":"C G Frostell","year":"1993","journal-title":"Anesthesiology"},{"issue":"06","key":"ref2","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/00000542-199112000-00011","article-title":"Inhaled nitric oxide. A selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep","volume":"75","author":"M D Fratacci","year":"1991","journal-title":"Anesthesiology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0140-6736(92)92687-B","article-title":"Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn","volume":"340","author":"J P Kinsella","year":"1992","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/0140-6736(92)92686-A","article-title":"Inhaled nitric oxide in persistent pulmonary hypertension of the newborn","volume":"340","author":"J D Roberts","year":"1992","journal-title":"Lancet"},{"issue":"06","key":"ref5","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1542\/peds.99.6.838","article-title":"Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia","volume":"99","author":"The Neonatal Inhaled Nitric Oxide Study Group (NINOS)","year":"1997","journal-title":"Pediatrics"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1203\/00006450-199704000-00002","article-title":"Effects of inhaled nitric oxide on pulmonary edema and lung neutrophil accumulation in severe experimental hyaline membrane disease","volume":"41","author":"J P Kinsella","year":"1997","journal-title":"Pediatr Res"},{"issue":"02","key":"ref7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/bph.14512","article-title":"Inhaled nitric oxide","volume":"176","author":"B Yu","year":"2019","journal-title":"Br J Pharmacol"},{"issue":"05","key":"ref8","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1164\/ajrccm.156.5.96-12012","article-title":"Factors influencing indoor concentrations of nitric oxide in a Parisian intensive care unit","volume":"156","author":"E Mourgeon","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"04","key":"ref9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/01.RES.0000087541.15600.2B","article-title":"Cyclic GMP phosphodiesterases and regulation of smooth muscle function","volume":"93","author":"S D Rybalkin","year":"2003","journal-title":"Circ Res"},{"issue":"02","key":"ref10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1172\/JCI115877","article-title":"Bronchodilator action of inhaled nitric oxide in guinea pigs","volume":"90","author":"P M Dupuy","year":"1992","journal-title":"J Clin Invest"},{"issue":"01","key":"ref11","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1164\/ajrccm.153.1.8542105","article-title":"Inhaled nitric oxide. A bronchodilator in mild asthmatics with methacholine-induced bronchospasm","volume":"153","author":"R M Kacmarek","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"02","key":"ref12","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1161\/01.RES.87.2.140","article-title":"Nitric oxide inhalation decreases pulmonary artery remodeling in the injured lungs of rat pups","volume":"87","author":"J D Roberts Jr","year":"2000","journal-title":"Circ Res"},{"issue":"03","key":"ref13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1540-8191.2009.00833.x","article-title":"Effects of inhaled nitric oxide following lung transplantation","volume":"24","author":"C Yerebakan","year":"2009","journal-title":"J Card Surg"},{"issue":"03","key":"ref14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1172\/JCI200524459","article-title":"NO\/redox disequilibrium in the failing heart and cardiovascular system","volume":"115","author":"J M Hare","year":"2005","journal-title":"J Clin Invest"},{"issue":"09","key":"ref15","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM199702273360902","article-title":"Inhaled nitric oxide and persistent pulmonary hypertension of the newborn","volume":"336","author":"J D Roberts Jr","year":"1997","journal-title":"N Engl J Med"},{"issue":"07","key":"ref16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1056\/NEJM200002173420704","article-title":"Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn","volume":"342","author":"R H Clark","year":"2000","journal-title":"N Engl J Med"},{"issue":"12","key":"ref17","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/jp.2010.37","article-title":"The changing pattern of inhaled nitric oxide use in the neonatal intensive care unit","volume":"30","author":"R H Clark","year":"2010","journal-title":"J Perinatol"},{"issue":"03","key":"ref18","doi-asserted-by":"crossref","first-page":"F191","DOI":"10.1136\/fn.77.3.F191","article-title":"Changes in oxygenation and pulmonary haemodynamics in preterm infants treated with inhaled nitric oxide","volume":"77","author":"N V Subhedar","year":"1997","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0140-6736(99)03558-8","article-title":"Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomised controlled trial","volume":"354","author":"J P Kinsella","year":"1999","journal-title":"Lancet"},{"issue":"S 02","key":"ref20","first-page":"S469","article-title":"Inhaled nitric oxide therapy in premature infants with mild to moderate respiratory distress syndrome","volume":"85","author":"P Srisuparp","year":"2002","journal-title":"J Med Assoc Thai"},{"issue":"04","key":"ref21","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1542\/peds.2004-1209","article-title":"Neonatal ventilation with inhaled nitric oxide versus ventilatory support without inhaled nitric oxide for preterm infants with severe respiratory failure: the INNOVO multicentre randomised controlled trial (ISRCTN 17821339)","volume":"115","author":"D Field","year":"2005","journal-title":"Pediatrics"},{"issue":"01","key":"ref22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa043927","article-title":"Inhaled nitric oxide for premature infants with severe respiratory failure","volume":"353","author":"K P Van Meurs","year":"2005","journal-title":"N Engl J Med"},{"issue":"04","key":"ref23","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa060442","article-title":"Early inhaled nitric oxide therapy in premature newborns with respiratory failure","volume":"355","author":"J P Kinsella","year":"2006","journal-title":"N Engl J Med"},{"issue":"04","key":"ref24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1056\/NEJMoa061088","article-title":"Inhaled nitric oxide in preterm infants undergoing mechanical ventilation","volume":"355","author":"R A Ballard","year":"2006","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0140-6736(10)60664-2","article-title":"Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trial","volume":"376","author":"J-C Mercier","year":"2010","journal-title":"Lancet"},{"issue":"03","key":"ref26","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jpeds.2004.10.019","article-title":"The safety and efficacy of nitric oxide therapy in premature infants","volume":"146","author":"J M Hascoet","year":"2005","journal-title":"J Pediatr"},{"issue":"06","key":"ref27","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJM199302113280605","article-title":"Inhaled nitric oxide for the adult respiratory distress syndrome","volume":"328","author":"R Rossaint","year":"1993","journal-title":"N Engl J Med"},{"issue":"07","key":"ref28","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1399-6576.1994.tb03970.x","article-title":"Inhaled nitric oxide lowers pulmonary capillary pressure and changes longitudinal distribution of pulmonary vascular resistance in patients with acute lung injury","volume":"38","author":"A Benzing","year":"1994","journal-title":"Acta Anaesthesiol Scand"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1164\/ajrccm.157.5.9707090","article-title":"Inhaled nitric oxide in acute respiratory distress syndrome: a pilot randomized controlled study","volume":"157","author":"E Troncy","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"13","key":"ref30","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1001\/jama.291.13.1603","article-title":"Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial","volume":"291","author":"R W Taylor","year":"2004","journal-title":"JAMA"},{"issue":"07","key":"ref31","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1164\/rccm.2108121","article-title":"Dose-response characteristics during long-term inhalation of nitric oxide in patients with severe acute respiratory distress syndrome: a prospective, randomized, controlled study","volume":"167","author":"H Gerlach","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"ref32","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/PCC.0000000000001305","article-title":"Association of response to inhaled nitric oxide and duration of mechanical ventilation in pediatric acute respiratory distress syndrome","volume":"18","author":"J C Dowell","year":"2017","journal-title":"Pediatr Crit Care Med"},{"issue":"02","key":"ref33","doi-asserted-by":"crossref","first-page":"365.e1","DOI":"10.1016\/j.jpeds.2014.10.011","article-title":"Multicenter randomized controlled trial of inhaled nitric oxide for pediatric acute respiratory distress syndrome","volume":"166","author":"R A Bronicki","year":"2015","journal-title":"J Pediatr"},{"issue":"08","key":"ref34","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/PCC.0000000000002310","article-title":"Inhaled nitric oxide use in pediatric hypoxemic respiratory failure","volume":"21","author":"J T Berger","year":"2020","journal-title":"Pediatr Crit Care Med"},{"issue":"05","key":"ref35","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1378\/chest.128.5.3537","article-title":"Effects of inhaled nitric oxide administration on early postoperative mortality in patients operated for correction of atrioventricular canal defects","volume":"128","author":"D Journois","year":"2005","journal-title":"Chest"},{"issue":"03","key":"ref36","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0022-5223(12)70258-1","article-title":"Very-low-dose inhaled nitric oxide: a selective pulmonary vasodilator after operations for congenital heart disease","volume":"108","author":"O I Miller","year":"1994","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"04","key":"ref37","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0022-5223(94)70390-6","article-title":"Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects","volume":"107","author":"D Journois","year":"1994","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/S0140-6736(00)02869-5","article-title":"Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised double-blind study","volume":"356","author":"O I Miller","year":"2000","journal-title":"Lancet"},{"issue":"08","key":"ref39","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1097\/00003246-200008000-00048","article-title":"Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease","volume":"28","author":"K Morris","year":"2000","journal-title":"Crit Care Med"},{"issue":"01","key":"ref40","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1213\/00000539-199807000-00011","article-title":"The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease","volume":"87","author":"I A Russell","year":"1998","journal-title":"Anesth Analg"},{"issue":"06","key":"ref41","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0003-4975(00)01312-6","article-title":"Randomized controlled study of inhaled nitric oxide after operation for congenital heart disease","volume":"69","author":"R W Day","year":"2000","journal-title":"Ann Thorac Surg"},{"issue":"07","key":"ref42","first-page":"CD005055","article-title":"Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease","author":"M Bizzarro","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"04","key":"ref43","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00246-012-0172-4","article-title":"Review of inhaled nitric oxide in the pediatric cardiac surgery setting","volume":"33","author":"P A Checchia","year":"2012","journal-title":"Pediatr Cardiol"},{"issue":"11","key":"ref44","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1007\/s00134-016-4420-6","article-title":"Nitric oxide administration during paediatric cardiopulmonary bypass: a randomised controlled trial","volume":"42","author":"C James","year":"2016","journal-title":"Intensive Care Med"},{"issue":"02","key":"ref45","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.transproceed.2019.11.034","article-title":"Impact of preoperative pulmonary hypertension on survival in patients undergoing elective heart transplant","volume":"52","author":"E M Cantero-P\u00e9rez","year":"2020","journal-title":"Transplant Proc"},{"issue":"04","key":"ref46","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/00007890-200108270-00013","article-title":"Inhaled nitric oxide for pulmonary hypertension after heart transplantation","volume":"72","author":"A Ardehali","year":"2001","journal-title":"Transplantation"},{"issue":"06","key":"ref47","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/0003-4975(92)90393-I","article-title":"Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device","volume":"53","author":"O H Frazier","year":"1992","journal-title":"Ann Thorac Surg"},{"issue":"03","key":"ref48","first-page":"312","article-title":"Adjunctive use of inhaled nitric oxide during implantation of a left ventricular assist device","volume":"17","author":"P S Macdonald","year":"1998","journal-title":"J Heart Lung Transplant"},{"issue":"02","key":"ref49","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0003-4975(97)01307-6","article-title":"Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension","volume":"65","author":"M Argenziano","year":"1998","journal-title":"Ann Thorac Surg"},{"issue":"08","key":"ref50","first-page":"870","article-title":"Inhaled nitric oxide after left ventricular assist device implantation: a prospective, randomized, double-blind, multicenter, placebo-controlled trial","volume":"30","author":"E Potapov","year":"2011","journal-title":"J Heart Lung Transplant"},{"issue":"03","key":"ref51","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6","article-title":"Pathophysiology of ischaemia-reperfusion injury","volume":"190","author":"D L Carden","year":"2000","journal-title":"J Pathol"},{"issue":"11","key":"ref52","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1172\/JCI2736","article-title":"Inhaled NO as a viable antiadhesive therapy for ischemia\/reperfusion injury of distal microvascular beds","volume":"101","author":"A Fox-Robichaud","year":"1998","journal-title":"J Clin Invest"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s13054-015-1050-2","article-title":"Inhaled nitric oxide improves transpulmonary blood flow and clinical outcomes after prolonged cardiac arrest: a large animal study","volume":"19","author":"M Derwall","year":"2015","journal-title":"Crit Care"},{"issue":"08","key":"ref54","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jacc.2007.04.069","article-title":"Nitric oxide inhalation improves microvascular flow and decreases infarction size after myocardial ischemia and reperfusion","volume":"50","author":"X Liu","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"ref55","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1161\/CIRCULATIONAHA.111.025395","article-title":"Inhaled nitric oxide improves outcomes after successful cardiopulmonary resuscitation in mice","volume":"124","author":"S Minamishima","year":"2011","journal-title":"Circulation"},{"issue":"06","key":"ref56","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1161\/CIRCULATIONAHA.117.032488","article-title":"Improvement in outcomes after cardiac arrest and resuscitation by inhibition of S-nitrosoglutathione reductase","volume":"139","author":"K Hayashida","year":"2019","journal-title":"Circulation"},{"issue":"02","key":"ref57","doi-asserted-by":"crossref","first-page":"e86053","DOI":"10.1371\/journal.pone.0086053","article-title":"A randomized clinical trial testing the anti-inflammatory effects of preemptive inhaled nitric oxide in human liver transplantation","volume":"9","author":"J D Lang Jr","year":"2014","journal-title":"PLoS One"},{"issue":"29","key":"ref58","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1093\/eurheartj\/ehy232","article-title":"Nitric oxide for inhalation in ST-elevation myocardial infarction (NOMI): a multicentre, double-blind, randomized controlled trial","volume":"39","author":"S P Janssens","year":"2018","journal-title":"Eur Heart J"},{"issue":"12","key":"ref59","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1172\/JCI25040","article-title":"Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin","volume":"115","author":"P C Minneci","year":"2005","journal-title":"J Clin Invest"},{"issue":"10","key":"ref60","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1164\/rccm.201710-2150OC","article-title":"Nitric oxide decreases acute kidney injury and stage 3 chronic kidney disease after cardiac surgery","volume":"198","author":"C Lei","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"01","key":"ref61","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.niox.2008.08.002","article-title":"Gaseous nitric oxide bactericidal activity retained during intermittent high-dose short duration exposure","volume":"20","author":"C Miller","year":"2009","journal-title":"Nitric Oxide"},{"issue":"06","key":"ref62","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jcf.2013.01.008","article-title":"Inhaled nitric oxide decreases the bacterial load in a rat model of Pseudomonas aeruginosa pneumonia","volume":"12","author":"C C Miller","year":"2013","journal-title":"J Cyst Fibros"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"101826","DOI":"10.1016\/j.redox.2020.101826","article-title":"Antimicrobial effects of nitric oxide in murine models of Klebsiella pneumonia","volume":"39","author":"S B Wiegand","year":"2021","journal-title":"Redox Biol"},{"key":"ref64","first-page":"1536714","article-title":"High-dose inhaled nitric oxide as adjunct therapy in cystic fibrosis targeting Burkholderia multivorans","volume":"2020","author":"B L Bartley","year":"2020","journal-title":"Case Rep Pediatr"},{"issue":"23","key":"ref65","doi-asserted-by":"crossref","first-page":"7333","DOI":"10.1128\/JB.00975-09","article-title":"Nitric oxide signaling in Pseudomonas aeruginosa biofilms mediates phosphodiesterase activity, decreased cyclic di-GMP levels, and enhanced dispersal","volume":"191","author":"N Barraud","year":"2009","journal-title":"J Bacteriol"},{"issue":"09","key":"ref66","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/j.ymthe.2017.06.021","article-title":"Low-dose nitric oxide as targeted anti-biofilm adjunctive therapy to treat chronic Pseudomonas aeruginosa infection in cystic fibrosis","volume":"25","author":"R P Howlin","year":"2017","journal-title":"Mol Ther"},{"issue":"08","key":"ref67","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1021\/acsinfecdis.9b00016","article-title":"Antibiofilm efficacy of nitric oxide-releasing alginates against cystic fibrosis bacterial pathogens","volume":"5","author":"M JR Ahonen","year":"2019","journal-title":"ACS Infect Dis"},{"issue":"01","key":"ref68","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ppul.23905","article-title":"Nitric oxide inhalations in bronchiolitis: a pilot, randomized, double-blinded, controlled trial","volume":"53","author":"A Tal","year":"2018","journal-title":"Pediatr Pulmonol"},{"issue":"10","key":"ref69","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1086\/425357","article-title":"Inhalation of nitric oxide in the treatment of severe acute respiratory syndrome: a rescue trial in Beijing","volume":"39","author":"L Chen","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"03","key":"ref70","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1128\/JVI.79.3.1966-1969.2005","article-title":"Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus","volume":"79","author":"S Akerstr\u00f6m","year":"2005","journal-title":"J Virol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"101734","DOI":"10.1016\/j.redox.2020.101734","article-title":"Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro","volume":"37","author":"D Akaberi","year":"2020","journal-title":"Redox Biol"},{"issue":"11","key":"ref72","doi-asserted-by":"crossref","first-page":"e0277","DOI":"10.1097\/CCE.0000000000000277","article-title":"Rescue treatment with high-dose gaseous nitric oxide in spontaneously breathing patients with severe coronavirus disease 2019","volume":"2","author":"S B Wiegand","year":"2020","journal-title":"Crit Care Explor"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.niox.2021.08.003","article-title":"Inhaled high dose nitric oxide is a safe and effective respiratory treatment in spontaneous breathing hospitalized patients with COVID-19 pneumonia","volume":"116","author":"B Safaee Fakhr","year":"2021","journal-title":"Nitric Oxide"},{"issue":"06","key":"ref74","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/AOG.0000000000004128","article-title":"High concentrations of nitric oxide inhalation therapy in pregnant patients with severe coronavirus disease 2019 (COVID-19)","volume":"136","author":"B Safaee Fakhr","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"02","key":"ref75","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/emj.2002.003483","article-title":"Heliox for asthma in the emergency department: a review of the literature","volume":"21","author":"A D Reuben","year":"2004","journal-title":"Emerg Med J"},{"issue":"01","key":"ref76","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2223\/JPED.36","article-title":"Helium-Oxigen (Heliox) mixture in airway obstruction [in Portuguese]","volume":"76","author":"C A Ulh\u00f4a","year":"2000","journal-title":"J Pediatr (Rio J)"},{"issue":"05","key":"ref77","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1515\/BMT.2005.018","article-title":"Cardiorespiratory effects of heliox using a model of upper airway obstruction [in German]","volume":"50","author":"S Enneper","year":"2005","journal-title":"Biomed Tech (Berl)"},{"issue":"09","key":"ref78","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1097\/00005537-200109000-00004","article-title":"Use of helium-oxygen mixtures to relieve upper airway obstruction in a pediatric population","volume":"111","author":"A H Grosz","year":"2001","journal-title":"Laryngoscope"},{"issue":"06","key":"ref79","first-page":"49","article-title":"Use of helium in the management of upper airway obstruction","volume":"142","author":"T Q Tan","year":"1990","journal-title":"J La State Med Soc"},{"issue":"04","key":"ref80","first-page":"12","article-title":"Heliox in upper airway obstruction","volume":"10","author":"A Fu","year":"1999","journal-title":"Off J Can Assoc Crit Care Nurs"},{"issue":"03","key":"ref81","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1164\/ajrccm\/147.3.524","article-title":"Deposition in asthmatics of particles inhaled in air or in helium-oxygen","volume":"147","author":"M Anderson","year":"1993","journal-title":"Am Rev Respir Dis"},{"issue":"01","key":"ref82","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1164\/ajrccm.163.1.2003025","article-title":"Improvement in aerosol delivery with helium-oxygen mixtures during mechanical ventilation","volume":"163","author":"M L Goode","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"03","key":"ref83","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/02770908909070987","article-title":"The use of helium-oxygen mixtures in the support of patients with status asthmaticus and respiratory acidosis","volume":"26","author":"S T Shiue","year":"1989","journal-title":"J Asthma"},{"issue":"03","key":"ref84","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1378\/chest.107.3.757","article-title":"Heliox therapy in acute severe asthma","volume":"107","author":"J E Kass","year":"1995","journal-title":"Chest"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1164\/ajrccm.151.2.7842183","article-title":"Heliox improves pulsus paradoxus and peak expiratory flow in nonintubated patients with severe asthma","volume":"151","author":"C A Manthous","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"04","key":"ref86","first-page":"CD002884","article-title":"Heliox for nonintubated acute asthma patients","volume":"2006","author":"G Rodrigo","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"06","key":"ref87","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1378\/chest.87.6.790","article-title":"Helium-oxygen breathing in severe chronic obstructive pulmonary disease","volume":"87","author":"D M Swidwa","year":"1985","journal-title":"Chest"},{"issue":"06","key":"ref88","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1378\/chest.125.6.2075","article-title":"Effect of heliox breathing on dynamic hyperinflation in COPD patients","volume":"125","author":"M Pecchiari","year":"2004","journal-title":"Chest"},{"issue":"03","key":"ref89","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/01.CCM.0000055369.37620.EE","article-title":"Helium-oxygen versus air-oxygen noninvasive pressure support in decompensated chronic obstructive disease: A prospective, multicenter study","volume":"31","author":"P Jolliet","year":"2003","journal-title":"Crit Care Med"},{"issue":"08","key":"ref90","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1097\/00003246-200008000-00006","article-title":"Effects of helium-oxygen on intrinsic positive end-expiratory pressure in intubated and mechanically ventilated patients with severe chronic obstructive pulmonary disease","volume":"28","author":"D Tassaux","year":"2000","journal-title":"Crit Care Med"},{"issue":"02","key":"ref91","first-page":"CD003571","article-title":"Heliox for treatment of exacerbations of chronic obstructive pulmonary disease","author":"G Rodrigo","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"issue":"09","key":"ref92","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1097\/00003246-200009000-00009","article-title":"Randomized trial of the use of heliox as a driving gas for updraft nebulization of bronchodilators in the emergent treatment of acute exacerbations of chronic obstructive pulmonary disease","volume":"28","author":"B P deBoisblanc","year":"2000","journal-title":"Crit Care Med"},{"issue":"04","key":"ref94","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1124\/pr.57.4.3","article-title":"Carbon monoxide: endogenous production, physiological functions, and pharmacological applications","volume":"57","author":"L Wu","year":"2005","journal-title":"Pharmacol Rev"},{"issue":"01","key":"ref95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/biof.192","article-title":"CO metabolism, sensing, and signaling","volume":"38","author":"F Gullotta","year":"2012","journal-title":"Biofactors"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev.pharmtox.46.120604.141053","article-title":"CO as a cellular signaling molecule","volume":"46","author":"H P Kim","year":"2006","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"05","key":"ref97","first-page":"379","article-title":"Carbon monoxide","volume":"19","author":"R Von Burg","year":"1999","journal-title":"J Appl Toxicol"},{"issue":"01","key":"ref98","doi-asserted-by":"crossref","first-page":"FSO59","DOI":"10.4155\/fso.15.59","article-title":"Nitric oxide: a brief overview of chemical and physical properties relevant to therapeutic applications","volume":"1","author":"J R Lancaster Jr","year":"2015","journal-title":"Future Sci OA"},{"issue":"01","key":"ref99","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0006-291X(75)80403-7","article-title":"Quantitative infrared spectroscopy of CO complexes of cytochrome c oxidase, hemoglobin and myoglobin: evidence for one CO per heme","volume":"62","author":"J A Volpe","year":"1975","journal-title":"Biochem Biophys Res Commun"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/978-1-4684-5643-1_84","article-title":"Reversal of carbon monoxide-cytochrome c oxidase binding by hyperbaric oxygen in vivo","volume":"248","author":"S D Brown","year":"1989","journal-title":"Adv Exp Med Biol"},{"issue":"01","key":"ref101","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1749-6632.1970.tb49788.x","article-title":"Factors influencing the inhibitory effect of carbon monoxide on cytochrome P-450-catalyzed mixed function oxidation reactions","volume":"174","author":"R W Estabrook","year":"1970","journal-title":"Ann N Y Acad Sci"},{"issue":"05","key":"ref102","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1074-5521(98)90618-4","article-title":"Synergistic activation of soluble guanylate cyclase by YC-1 and carbon monoxide: implications for the role of cleavage of the iron-histidine bond during activation by nitric oxide","volume":"5","author":"J R Stone","year":"1998","journal-title":"Chem Biol"},{"key":"ref103","first-page":"52","article-title":"Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light","volume":"28","author":"R F Furchgott","year":"1991","journal-title":"Blood Vessels"},{"key":"ref104","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1042\/bj3580201","article-title":"Kinetics of CO binding to the haem domain of murine inducible nitric oxide synthase: differential effects of haem domain ligands","volume":"358","author":"T H Stevenson","year":"2001","journal-title":"Biochem J"},{"issue":"18","key":"ref105","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.1021\/bi00184a036","article-title":"Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states","volume":"33","author":"J R Stone","year":"1994","journal-title":"Biochemistry"},{"issue":"02","key":"ref106","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1006\/bbrc.1994.2811","article-title":"Carbon monoxide as an endogenous modulator of hepatic vascular perfusion","volume":"205","author":"M Suematsu","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1126\/science.7678352","article-title":"Carbon monoxide: a putative neural messenger","volume":"259","author":"A Verma","year":"1993","journal-title":"Science"},{"issue":"52","key":"ref108","doi-asserted-by":"crossref","first-page":"32804","DOI":"10.1074\/jbc.272.52.32804","article-title":"Carbon monoxide controls the proliferation of hypoxic vascular smooth muscle cells","volume":"272","author":"T Morita","year":"1997","journal-title":"J Biol Chem"},{"issue":"04","key":"ref109","first-page":"497","article-title":"Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase","volume":"32","author":"B Br\u00fcne","year":"1987","journal-title":"Mol Pharmacol"},{"issue":"01","key":"ref110","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1749-6632.1970.tb49786.x","article-title":"Mitochondrial responses to carbon monoxide toxicity","volume":"174","author":"B Chance","year":"1970","journal-title":"Ann N Y Acad Sci"},{"issue":"04","key":"ref111","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1165\/rcmb.2010-0352OC","article-title":"Carbon monoxide activates autophagy via mitochondrial reactive oxygen species formation","volume":"45","author":"S-J Lee","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"12","key":"ref112","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1073\/pnas.0609611104","article-title":"Hypoxia-inducible factor 1alpha stabilization by carbon monoxide results in cytoprotective preconditioning","volume":"104","author":"B Y Chin","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"04","key":"ref113","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1096\/fj.06-6644com","article-title":"Carbon monoxide signals via inhibition of cytochrome c oxidase and generation of mitochondrial reactive oxygen species","volume":"21","author":"B S Zuckerbraun","year":"2007","journal-title":"FASEB J"},{"issue":"05","key":"ref114","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.immuni.2006.03.012","article-title":"Carbon monoxide orchestrates a protective response through PPARgamma","volume":"24","author":"M Bilban","year":"2006","journal-title":"Immunity"},{"issue":"12","key":"ref115","first-page":"3730","article-title":"The CO\/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy","volume":"117","author":"H B Suliman","year":"2007","journal-title":"J Clin Invest"},{"key":"ref116","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1242\/jcs.03318","article-title":"A new activating role for CO in cardiac mitochondrial biogenesis","volume":"120","author":"H B Suliman","year":"2007","journal-title":"J Cell Sci"},{"issue":"02","key":"ref117","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1124\/jpet.108.148049","article-title":"Carbon monoxide rescues mice from lethal sepsis by supporting mitochondrial energetic metabolism and activating mitochondrial biogenesis","volume":"329","author":"S Lancel","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"issue":"28","key":"ref118","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1039\/C3CC49196J","article-title":"Carbon monoxide\u2013physiology, detection and controlled release","volume":"50","author":"S H Heinemann","year":"2014","journal-title":"Chem Commun (Camb)"},{"issue":"01","key":"ref119","doi-asserted-by":"crossref","first-page":"H1","DOI":"10.1152\/ajpheart.00230.2011","article-title":"Carbon monoxide as an endogenous vascular modulator","volume":"301","author":"C W Leffler","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"10","key":"ref120","first-page":"1768","article-title":"U.S. mortality due to carbon monoxide poisoning, 1999-2014. accidental and intentional deaths","volume":"13","author":"N BUS Hampson","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"11","key":"ref121","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1164\/rccm.201207-1284CI","article-title":"Practice recommendations in the diagnosis, management, and prevention of carbon monoxide poisoning","volume":"186","author":"N B Hampson","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"05","key":"ref122","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1164\/rccm.200701-026OC","article-title":"Carbon monoxide poisoning: risk factors for cognitive sequelae and the role of hyperbaric oxygen","volume":"176","author":"L K Weaver","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"06","key":"ref123","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ajem.2007.10.005","article-title":"Carboxyhemoglobin levels in carbon monoxide poisoning: do they correlate with the clinical picture?","volume":"26","author":"N B Hampson","year":"2008","journal-title":"Am J Emerg Med"},{"issue":"04","key":"ref124","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ccc.2012.07.007","article-title":"Carbon monoxide poisoning","volume":"28","author":"J A Guzman","year":"2012","journal-title":"Crit Care Clin"},{"issue":"02","key":"ref125","doi-asserted-by":"crossref","first-page":"C211","DOI":"10.1152\/ajpcell.00022.2017","article-title":"Carbon monoxide in lung cell physiology and disease","volume":"314","author":"S W Ryter","year":"2018","journal-title":"Am J Physiol Cell Physiol"},{"issue":"08","key":"ref126","doi-asserted-by":"crossref","first-page":"L834","DOI":"10.1152\/ajplung.00240.2015","article-title":"Effects of inhaled CO administration on acute lung injury in baboons with pneumococcal pneumonia","volume":"309","author":"L E Fredenburgh","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"12","key":"ref127","doi-asserted-by":"crossref","first-page":"L1387","DOI":"10.1152\/ajplung.00311.2015","article-title":"Carbon monoxide in the treatment of sepsis","volume":"309","author":"K Nakahira","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"05","key":"ref128","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1097\/CCM.0b013e31819efa31","article-title":"Carbon monoxide prevents ventilator-induced lung injury via caveolin-1","volume":"37","author":"A Hoetzel","year":"2009","journal-title":"Crit Care Med"},{"issue":"12","key":"ref129","doi-asserted-by":"crossref","first-page":"6378","DOI":"10.4049\/jimmunol.1202969","article-title":"Inhaled carbon monoxide accelerates resolution of inflammation via unique proresolving mediator-heme oxygenase-1 circuits","volume":"190","author":"N Chiang","year":"2013","journal-title":"J Immunol"},{"issue":"10","key":"ref130","doi-asserted-by":"crossref","first-page":"L1058","DOI":"10.1152\/ajplung.00400.2014","article-title":"Carbon monoxide negatively regulates NLRP3 inflammasome activation in macrophages","volume":"308","author":"S-S Jung","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"23","key":"ref131","doi-asserted-by":"crossref","first-page":"124039","DOI":"10.1172\/jci.insight.124039","article-title":"A phase I trial of low-dose inhaled carbon monoxide in sepsis-induced ARDS","volume":"3","author":"L E Fredenburgh","year":"2018","journal-title":"JCI Insight"},{"issue":"01","key":"ref132","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0002-9440(10)62229-8","article-title":"Carbon monoxide suppresses bleomycin-induced lung fibrosis","volume":"166","author":"Z Zhou","year":"2005","journal-title":"Am J Pathol"},{"issue":"01","key":"ref133","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.chest.2017.09.052","article-title":"A phase II clinical trial of low-dose inhaled carbon monoxide in idiopathic pulmonary fibrosis","volume":"153","author":"I O Rosas","year":"2018","journal-title":"Chest"},{"issue":"09","key":"ref134","doi-asserted-by":"crossref","first-page":"e825","DOI":"10.1097\/CCM.0000000000003299","article-title":"Clinical practice guidelines for the prevention and management of pain, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU","volume":"46","author":"J W Devlin","year":"2018","journal-title":"Crit Care Med"},{"issue":"02","key":"ref135","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/ACO.0000000000000174","article-title":"Sedation\/drugs used in intensive care sedation","volume":"28","author":"V J Page","year":"2015","journal-title":"Curr Opin Anaesthesiol"},{"issue":"03","key":"ref136","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bpa.2005.01.003","article-title":"Pharmacology of modern volatile anaesthetics","volume":"19","author":"B Preckel","year":"2005","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"03","key":"ref137","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.bpa.2005.02.006","article-title":"Inhalational anaesthetics in the ICU: theory and practice of inhalational sedation in the ICU, economics, risk-benefit","volume":"19","author":"A Meiser","year":"2005","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"05","key":"ref138","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1046\/j.1365-2044.2001.01900.x","article-title":"A new device to reduce the consumption of a halogenated anaesthetic agent","volume":"56","author":"M Enlund","year":"2001","journal-title":"Anaesthesia"},{"issue":"04","key":"ref139","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1213\/00000539-199704000-00039","article-title":"Hypothesis: inhaled anesthetics produce immobility and amnesia by different mechanisms at different sites","volume":"84","author":"E I Eger II","year":"1997","journal-title":"Anesth Analg"},{"issue":"02","key":"ref140","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00000542-198608000-00013","article-title":"The extent of metabolism of inhaled anesthetics in humans","volume":"65","author":"R L Carpenter","year":"1986","journal-title":"Anesthesiology"},{"issue":"49","key":"ref141","doi-asserted-by":"crossref","first-page":"e8976","DOI":"10.1097\/MD.0000000000008976","article-title":"Volatile sedation in the intensive care unit: a systematic review and meta-analysis","volume":"96","author":"H Y Kim","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"04","key":"ref142","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/bja\/53.4.351","article-title":"Non-invasive measurement of cardiac output during anaesthesia. An evaluation of the soluble gas uptake method","volume":"53","author":"C PH Heneghan","year":"1981","journal-title":"Br J Anaesth"},{"issue":"03","key":"ref143","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s002590000459","article-title":"Validation of myocardial blood flow estimation with nitrogen-13 ammonia PET by the argon inert gas technique in humans","volume":"28","author":"J Kotzerke","year":"2001","journal-title":"Eur J Nucl Med"},{"issue":"01","key":"ref144","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/SHK.0000000000000049","article-title":"Postresuscitation treatment with argon improves early neurological recovery in a porcine model of cardiac arrest","volume":"41","author":"G Ristagno","year":"2014","journal-title":"Shock"},{"issue":"11","key":"ref145","doi-asserted-by":"crossref","first-page":"E1816","DOI":"10.3390\/ijms17111816","article-title":"The molecular pathway of argon-mediated neuroprotection","volume":"17","author":"F Ulbrich","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"02","key":"ref146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004311-200104000-00003","article-title":"Xenon in anesthesia","volume":"39","author":"T S Aziz","year":"2001","journal-title":"Int Anesthesiol Clin"},{"issue":"02","key":"ref147","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1213\/ane.0b013e3181aa9550","article-title":"A closed-circuit neonatal xenon delivery system: a technical and practical neuroprotection feasibility study in newborn pigs","volume":"109","author":"E Chakkarapani","year":"2009","journal-title":"Anesth Analg"},{"key":"ref148","first-page":"37","article-title":"Xenon: recent developments and future perspectives","volume":"75","author":"M Derwall","year":"2009","journal-title":"Minerva Anestesiol"},{"issue":"05","key":"ref149","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/01.anes.0000287061.77674.71","article-title":"Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor by the anesthetics xenon and isoflurane: evidence from molecular modeling and electrophysiology","volume":"107","author":"R Dickinson","year":"2007","journal-title":"Anesthesiology"},{"issue":"03","key":"ref150","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/ALN.0b013e3181cf894a","article-title":"Noble gas xenon is a novel adenosine triphosphate-sensitive potassium channel opener","volume":"112","author":"C Bantel","year":"2010","journal-title":"Anesthesiology"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"S492","DOI":"10.1097\/CCM.0b013e31818a904a","article-title":"Neuroprotective effects of the inhalational anesthetics isoflurane and xenon after cardiac arrest in pigs","volume":"36","author":"M Derwall","year":"2008","journal-title":"Crit Care Med"},{"issue":"04","key":"ref152","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/CCM.0b013e31823c8ce7","article-title":"Combining xenon and mild therapeutic hypothermia preserves neurological function after prolonged cardiac arrest in pigs","volume":"40","author":"M Fries","year":"2012","journal-title":"Crit Care Med"},{"issue":"09","key":"ref153","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1097\/CCM.0b013e31828a4337","article-title":"Feasibility and cardiac safety of inhaled xenon in combination with therapeutic hypothermia following out-of-hospital cardiac arrest","volume":"41","author":"O J Arola","year":"2013","journal-title":"Crit Care Med"},{"issue":"06","key":"ref154","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nm1577","article-title":"Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals","volume":"13","author":"I Ohsawa","year":"2007","journal-title":"Nat Med"},{"issue":"05","key":"ref155","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/SHK.0b013e3181def9aa","article-title":"Hydrogen gas improves survival rate and organ damage in zymosan-induced generalized inflammation model","volume":"34","author":"K Xie","year":"2010","journal-title":"Shock"},{"key":"ref156","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.lfs.2016.03.015","article-title":"Protection of donor lung inflation in the setting of cold ischemia against ischemia-reperfusion injury with carbon monoxide, hydrogen, or both in rats","volume":"151","author":"C Meng","year":"2016","journal-title":"Life Sci"},{"issue":"01","key":"ref157","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jss.2015.02.042","article-title":"Hydrogen gas inhibits high-mobility group box 1 release in septic mice by upregulation of heme oxygenase 1","volume":"196","author":"Y Li","year":"2015","journal-title":"J Surg Res"},{"issue":"02","key":"ref158","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jss.2016.01.009","article-title":"Effects of hydrogen-rich saline on aquaporin 1, 5 in septic rat lungs","volume":"202","author":"B Tao","year":"2016","journal-title":"J Surg Res"},{"key":"ref159","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.neuroscience.2016.08.021","article-title":"Inhalation of water electrolysis-derived hydrogen ameliorates cerebral ischemia-reperfusion injury in rats - a possible new hydrogen resource for clinical use","volume":"335","author":"J Cui","year":"2016","journal-title":"Neuroscience"},{"issue":"11","key":"ref160","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/WNR.0000000000000824","article-title":"Molecular hydrogen inhalation attenuates postoperative cognitive impairment in rats","volume":"28","author":"Y Xin","year":"2017","journal-title":"Neuroreport"},{"issue":"01","key":"ref161","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1471-4159.2010.06580.x","article-title":"Hydrogen sulfide as a gasotransmitter","volume":"113","author":"M M Gadalla","year":"2010","journal-title":"J Neurochem"},{"issue":"03","key":"ref162","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/jcbfm.2014.223","article-title":"Hydrogen sulfide inhalation decreases early blood-brain barrier permeability and brain edema induced by cardiac arrest and resuscitation","volume":"35","author":"Y Geng","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"issue":"04","key":"ref163","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1159\/000430316","article-title":"Hydrogen sulfide inhalation improves neurological outcome via NF-\u03baB-mediated inflammatory pathway in a rat model of cardiac arrest and resuscitation","volume":"36","author":"X Wei","year":"2015","journal-title":"Cell Physiol Biochem"},{"issue":"01","key":"ref164","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1038\/s41467-021-23363-x","article-title":"Sulfide catabolism ameliorates hypoxic brain injury","volume":"12","author":"E Marutani","year":"2021","journal-title":"Nat Commun"}],"container-title":["Seminars in Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0042-1747966.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T05:22:51Z","timestamp":1727155371000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0042-1747966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,9]]},"references-count":163,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2022,7,27]]},"published-print":{"date-parts":[[2022,6]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0042-1747966","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1069-3424","1098-9048"],"issn-type":[{"value":"1069-3424","type":"print"},{"value":"1098-9048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,9]]}}}